Scott Kopetz
Scott Kopetz publishes mostly in Oncology, Cancer Research and Molecular Biology, on topics such as Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics and Genetic factors in colorectal cancer.
- World rank
- #8,436 of 7,710,434 ranked researchers
- Rank in United States
- #2,907 of 1,627,098
- Works
- 1,997
- Citations
- 60k
- Citations per work
- 30.3
What does Scott Kopetz research?
Scott Kopetz's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (24%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1,19459.8%
- Medicine1,19459.8%
- Life Sciences46923.5%
- Everything else33316.7%
- 1Oncology36% of their works
- 2Cancer Research13% of their works
- 3Molecular Biology10% of their works
- 4Pulmonary and Respiratory Medicine10% of their works
- 5Pathology and Forensic Medicine10% of their works
- 6Surgery4% of their works
Research topics
Which keywords describe Scott Kopetz's research?
The keywords of their largest research topics: Cetuximab, KRAS Mutations, Targeted Therapy, Adjuvant Chemotherapy, Cancer Genomics, Mutational Signatures, Microsatellite Instability and Molecular Characterization.
- Chemotherapy-Induced Peripheral Neuropathy
- Preoperative Chemoradiotherapy
- Hepatocellular Carcinoma
- Immune Checkpoint Blockade
- ALK Inhibitors
- Molecular Characterization
- Mutational Signatures
- Adjuvant Chemotherapy
- KRAS Mutations
- Cetuximab
- Targeted Therapy
- Cancer Genomics
- Microsatellite Instability
- Clinical Practice Guidelines
- EGFR Mutations
- PD-1 and PD-L1
- Liver Cancer
- Rectal Cancer
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cetuximab6041 topic
- KRAS Mutations6041 topic
- Targeted Therapy5102 topics
- Adjuvant Chemotherapy3702 topics
- Cancer Genomics3471 topic
- Mutational Signatures3471 topic
- Microsatellite Instability2891 topic
- Molecular Characterization2891 topic
- Clinical Practice Guidelines1712 topics
- ALK Inhibitors1631 topic
- EGFR Mutations1631 topic
- Immune Checkpoint Blockade1181 topic
- PD-1 and PD-L11181 topic
- Hepatocellular Carcinoma901 topic
- Liver Cancer901 topic
- Preoperative Chemoradiotherapy811 topic
- Rectal Cancer811 topic
- Chemotherapy-Induced Peripheral Neuropathy701 topic
- Taxanes701 topic
Where does Scott Kopetz work?
Scott Kopetz's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.
How many publications and citations does Scott Kopetz have?
OpenAlex counts 1,997 works and 60,431 citations for Scott Kopetz, an h-index of 114, ranking #8,436 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Scott Kopetz
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Scott Kopetz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.